Stroke is one of the leading causes of mortality and adult disability in the world1,2,3. The occurrence of stroke and stroke-related illness is expected to triple by 20504, due to our vulnerable aging population and ongoing epidemics of diabetes and obesity1,5. Disabilities associated with stroke survivors have had a significant social and economic impact on societies worldwide2. According to the World Health Organization, about 15 million people worldwide suffer a stroke every year. Furthermore, stroke and its related illnesses cost the healthcare system billions of dollars each year, thus becoming significant financial burden and causing economic hardship in the world.
While stroke is a major public health concern, the cellular and molecular mechanisms underlying brain damage following stroke are not yet fully elucidated. A series of pathophysiological events are triggered during stroke, and eventually lead to intracellular ionic imbalance and cell death6,7. Glutamate mechanisms have dominated in stroke research for the last two to three decades8. Although glutamate receptor antagonists are effective in reducing stroke-related neuronal injury in the laboratory setting, clinical trials of anti-excitotoxic therapies have failed to benefit stroke patients9. Thus, researchers have started looking beyond glutamate mechanisms in cerebral ischemia and stroke. Recent convincing and promising results, especially from in vivo animal studies, suggest non-glutamate mechanisms are also important in causing ionic imbalance and cell death during cerebral ischemia8,10. Along with the traditional model of excitotoxicity focused on glutamate-receptor-mediated mechanisms, non-glutamate mechanisms are gaining considerable attention in recent years8,10. The latter include acid-sensing ion channels11,12, TRP channels13,14, KATP channels15,16, hemichannels17,18, volume-regulated anion channels19, adenosine receptors, sodium-calcium exchangers, and other ion exchangers and nonselective cation channels.
In this special issue of stroke research, we aim to cover the revised models of neuronal injury involving glutamate mechanisms and several newly identified non-glutamate mechanisms in stroke. We will discuss the current understanding of pathophysiological roles of ion channels and exchangers involved in non-glutamate mechanisms in cerebral ischemia and stroke, as well as the potential for therapeutic intervention. We will describe new studies using recently developed experimental models for stroke research. The primary scope of our reviews is to highlight findings from in vivo studies involving new strategies and drug developments for stroke treatment. The in vivo experimental approaches cover state of the art techniques currently used in the fields including molecular, genomic, proteomic, in vivo functional and behavioural assessments. We intend to highlight novel therapeutic strategies targeting non-glutamate mechanisms to prevent neuronal damage in stroke and to promote neuronal survival, regeneration and functional recovery after stroke, thus providing long-term economic, social, and healthcare benefits worldwide.
References
Canadian Diabetes Association Website, http://www.diabetes.ca/diabetes-and-you/living/complications/heart-disease-stroke/, 2005.
Stroke. http://www.strokeassociation.org/STROKEORG/AboutStroke/About-Stroke_UCM_308529_SubHomePage.jsp, 2000.
Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, et al. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–151.
Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA . Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 2003; 60: 1119–22.
Yach D, Hawkes C, Gould CL, Hofman KJ . The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291: 2616–22.
Dirnagl U, Iadecola C, Moskowitz MA . Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391–7.
Lipton P . Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431–568.
Besancon E, Guo S, Lok J, Tymianski M, Lo EH . Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke. Trends Pharmacol Sci 2008; 29: 268–75.
Davis SM, Lees KR, Albers GW, Diener HC, Markabi S, Karlsson G, et al. Selfotel in acute ischemic stroke: possible neurotoxic effects of an NMDA antagonist. Stroke 2000; 31: 347–54.
Tymianski M . Emerging mechanisms of disrupted cellular signaling in brain ischemia. Nat Neurosci 2011; 14: 1369–73.
Pignataro G, Simon RP, Xiong ZG . Prolonged activation of ASIC1a and the time window for neuroprotection in cerebral ischaemia. Brain 2007; 130: 151–8.
Xiong ZG, Zhu XM, Chu XP, Minami M, Hey J, Wei WL, et al. Neuroprotection in ischemia: blocking calcium-permeable acid-sensing ion channels. Cell 2004; 118: 687–98.
Aarts M, Iihara K, Wei WL, Xiong ZG, Arundine M, Cerwinski W, et al. A key role for TRPM7 channels in anoxic neuronal death. Cell 2003; 115: 863–77.
Sun HS, Jackson MF, Martin LJ, Jansen K, Teves L, Cui H, et al. Suppression of hippocampal TRPM7 protein prevents delayed neuronal death in brain ischemia. Nat Neurosci 2009; 12: 1300–7.
Sun HS, Feng ZP, Barber PA, Buchan AM, French RJ . Kir6.2-containing ATP-sensitive potassium channels protect cortical neurons from ischemic/anoxic injury in vitro and in vivo. Neuroscience 2007; 144: 1509–15.
Sun HS, Feng ZP, Miki T, Seino S, French RJ . Enhanced neuronal damage after ischemic insults in mice lacking Kir6.2-containing ATP-sensitive K+ channels. J Neurophysiol 2006; 95: 2590–601.
Thompson RJ, Jackson MF, Olah ME, Rungta RL, Hines DJ, Beazely MA, et al. Activation of pannexin-1 hemichannels augments aberrant bursting in the hippocampus. Science 2008; 322: 1555–9.
Thompson RJ, Zhou N, MacVicar BA . Ischemia opens neuronal gap junction hemichannels. Science 2006; 312: 924–7.
Zhang Y, Zhang H, Feustel PJ, Kimelberg HK . DCPIB, a specific inhibitor of volume regulated anion channels (VRACs), reduces infarct size in MCAO and the release of glutamate in the ischemic cortical penumbra. Exp Neurol 2008; 210: 514–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sun, Hs. Current mechanisms in stroke. Acta Pharmacol Sin 34, 1–2 (2013). https://doi.org/10.1038/aps.2012.174
Published:
Issue Date:
DOI: https://doi.org/10.1038/aps.2012.174
This article is cited by
-
Permeability Estimation of Shale Oil Reservoir with Laboratory-derived Data: A Case Study of the Chang 7 Member in Ordos Basin
Applied Geophysics (2023)
-
Log interpretation method of resistivity low-contrast oil pays in Chang 8 tight sandstone of Huanxian area, Ordos Basin by support vector machine
Scientific Reports (2022)
-
Characteristics, Types, and Prospects of Geological Sweet Sections in Giant Continental Shale Oil Provinces in China
Journal of Earth Science (2022)
-
Quantitative characterization and distribution of petrologically superior sandbodies in a shallow-water delta: Chang 81 sub-member, Triassic Yanchang Formation, Longdong area, Ordos Basin, China
Arabian Journal of Geosciences (2022)
-
Micropore structure and water driving characteristics of tight sandstone reservoirs in Ordos Basin
Journal of Petroleum Exploration and Production Technology (2022)